Experienced in Progressive Multifocal Leukoencephalopathy

Murat Dizbay

Gazi, TR 
Experienced in Progressive Multifocal Leukoencephalopathy
Gazi, TR 
OverviewLocationsClinical Research

Overview

Murat Dizbay practices in Gazi, Turkey. Mr. Dizbay is rated as an Experienced expert by MediFind in the treatment of Progressive Multifocal Leukoencephalopathy. His top areas of expertise are Sepsis, Urinary Tract Infection (UTI), Febrile Neutropenia, and COVID-19.

His clinical research consists of co-authoring 59 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Progressive Multifocal Leukoencephalopathy.

Gender
Male

Locations

Gazi, Turkey
Other Locations
Mevlana Boulevard, No, 29 P.C Yenimahalle, Yenimahalle, 06560, Turkey
Ankara, Turkey
Besevler, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Efficacy, Immunogenicity, and Safety of the Two-Dose Inactivated COVID-19 Vaccine (TURKOVAC) Versus the Two-Dose CoronaVac (Sinovac) Vaccine in Healthy Subjects: A Randomized, Observer-Blinded, Phase III Clinical Trial
Efficacy, Immunogenicity, and Safety of the Two-Dose Inactivated COVID-19 Vaccine (TURKOVAC) Versus the Two-Dose CoronaVac (Sinovac) Vaccine in Healthy Subjects: A Randomized, Observer-Blinded, Phase III Clinical Trial
Enrollment Status: Completed
Publish Date: February 29, 2024
Intervention Type: Biological
Study Phase: Phase 3

59 Total Publications

Combination therapy does not decrease 30-day mortality but increases antibiotic consumption in methicillin-sensitive S. aureus bacteraemia.
Combination therapy does not decrease 30-day mortality but increases antibiotic consumption in methicillin-sensitive S. aureus bacteraemia.
Journal: Journal of chemotherapy (Florence, Italy)
Published: September 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dizbay's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile